Injuries & OrthopedicsA clinical, evidence-graded ranking of peptide drugs for osteoporosis — from the FDA-approved PTH-receptor anabolics with Grade A fracture-reduction RCTs to salmon calcitonin's regulatory demotion and the entirely unproven grey-market 'bone peptides.'
Injuries & Orthopedics12 MIN READ
Injuries & OrthopedicsA clinical, evidence-graded ranking of the peptides studied for bone — from the FDA-approved PTH-class anabolics with Grade A fracture-prevention RCTs to the entirely preclinical regenerative peptides.
Injuries & Orthopedics12 MIN READ
Peptide EncyclopediaA clinical monograph on abaloparatide (Tymlos) — the FDA-approved PTHrP(1-34) bone-anabolic peptide. Phase 3 RCT fracture data in women and men, RG-selective PTH1R mechanism, and 2026 regulatory status.
Peptide Encyclopedia12 MIN READ